Medicare Part B premium reduction won’t happen this year

Medicare officials have determined that a mid-year change is not feasible, despite significant cost savings related to coverage of Alzheimer's drug Aduhelm.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.